T. Romer, Treatment of recurrent bleeding disorders during hormone replacement therapy by transcervical endometrial ablation, GYNECOL OBS, 47(4), 1999, pp. 255-257
If bleeding disorders, which could not be treated by modification of steroi
d dosages, occurred during sequential hormone replacement therapy (HRT), mo
st of the patients stopped HRT. In these cases a diagnostic outpatient hyst
eroscopy with biopsy was carried out. In most of the cases no intrauterine
cause for the bleeding disorder was found. In 35 patients we performed an e
ndometrial ablation without intra- or postoperative complications. After th
is procedure all patients received a combined continuous HRT. In a follow-u
p of 12 months 34 patients were amenorrheic and satisfied with the treatmen
t. One patient stopped HRT because of suffering from other side effects. En
dometrial ablation represents a method of treating patients with bleeding d
isorders without intrauterine causes with a minimal invasive procedure. A c
ontinuous combined HRT is possible after the endometrial ablation in perime
nopausal and postmenopausal patients without bleeding disorders. In selecte
d cases endometrial ablation can contribute to the increase of the complian
ce with HRT.